End-stage renal failure
Conditions
Interventions
Test group: Sacubitril valsartan sodium hydrate use group.
ARB group: RAS inhibitor use group.
Control group: Sacubitril valsartan sodium hydrate and no RAS inhibitor.
Sponsors
International University of Health and Welfare
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: This study targets peritoneal patients who are visiting the International University of Health and Welfare Hospital, the International University of Health and Welfare Narita Hospital, and the Keio University Hospital, and who have consented to participate in the study.Patients should be less than 3 months after the introduction of peritoneal dialysis.
Exclusion criteria
Exclusion criteria: Those who did not consent to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the rate of decrease in residual renal function in each group after 6 months of distribution to 3 groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of blood pressure in each group after 6 months of distribution to 3 groups .Comparison of cardiac function (EF) by Biplane Modified Simpson method in each group after 6 months of 3 groups.Comparison of peritoneal function in each group after 6 months of distribution to 3 groups. | — |
Countries
Japan
Contacts
Public ContactKazuya Sugita
International University of Health and Welfare Kidney Internal Medicine Course
Outcome results
None listed